Charles River Laboratories Quick Ratio 2010-2025 | CRL

Historical quick ratio values for Charles River Laboratories (CRL) over the last 10 years.
Charles River Laboratories Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2025-03-31 $1.22B $1.05B 1.16
2024-12-31 $1.13B $0.99B 1.13
2024-09-30 $1.16B $1.01B 1.15
2024-06-30 $1.15B $0.95B 1.21
2024-03-31 $1.31B $0.96B 1.37
2023-12-31 $1.23B $1.06B 1.16
2023-09-30 $1.15B $0.99B 1.16
2023-06-30 $1.22B $1.01B 1.21
2023-03-31 $1.19B $0.98B 1.21
2022-12-31 $1.18B $1.09B 1.08
2022-09-30 $1.15B $1.01B 1.14
2022-06-30 $1.14B $1.05B 1.08
2022-03-31 $1.11B $0.99B 1.12
2021-12-31 $1.08B $1.03B 1.04
2021-09-30 $1.20B $0.98B 1.22
2021-06-30 $1.07B $0.93B 1.16
2021-03-31 $1.23B $0.80B 1.53
2020-12-31 $1.02B $0.84B 1.21
2020-09-30 $0.96B $0.79B 1.22
2020-06-30 $1.07B $0.73B 1.47
2020-03-31 $1.05B $0.69B 1.51
2019-12-31 $0.86B $0.71B 1.21
2019-09-30 $0.82B $0.68B 1.20
2019-06-30 $0.88B $0.64B 1.38
2019-03-31 $0.74B $0.53B 1.39
2018-12-31 $0.77B $0.56B 1.38
2018-09-30 $0.71B $0.54B 1.32
2018-06-30 $0.77B $0.52B 1.48
2018-03-31 $0.72B $0.41B 1.78
2017-12-31 $0.71B $0.46B 1.54
2017-09-30 $0.68B $0.42B 1.62
2017-06-30 $0.63B $0.42B 1.49
2017-03-31 $0.60B $0.38B 1.57
2016-12-31 $0.56B $0.43B 1.31
2016-09-30 $0.56B $0.41B 1.35
2016-06-30 $0.60B $0.41B 1.46
2016-03-31 $0.54B $0.31B 1.74
2015-12-31 $0.47B $0.31B 1.49
2015-09-30 $0.48B $0.31B 1.53
2015-06-30 $0.54B $0.28B 1.95
2015-03-31 $0.53B $0.27B 1.95
2014-12-31 $0.49B $0.30B 1.66
2014-09-30 $0.51B $0.28B 1.81
2014-06-30 $0.50B $0.27B 1.84
2014-03-31 $0.50B $0.24B 2.09
2013-12-31 $0.46B $0.25B 1.88
2013-09-30 $0.46B $0.24B 1.96
2013-06-30 $0.43B $0.23B 1.91
2013-03-31 $0.41B $0.33B 1.23
2012-12-31 $0.40B $0.34B 1.16
2012-09-30 $0.36B $0.33B 1.12
2012-06-30 $0.36B $0.33B 1.10
2012-03-31 $0.35B $0.22B 1.55
2011-12-31 $0.33B $0.22B 1.54
2011-09-30 $0.36B $0.22B 1.62
2011-06-30 $0.45B $0.28B 1.62
2011-03-31 $0.46B $0.31B 1.50
2010-12-31 $0.45B $0.26B 1.74
2010-09-30 $0.43B $0.24B 1.80
2010-06-30 $0.51B $0.25B 2.08
2010-03-31 $0.52B $0.25B 2.09
2009-12-31 $0.49B $0.25B 1.97
2009-09-30 $0.47B $0.25B 1.83
2009-06-30 $0.47B $0.27B 1.76
2009-03-31 $0.48B $0.28B 1.73
Sector Industry Market Cap Revenue
Medical Medical Services $7.243B $4.050B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $142.561B 26.74
Elevance Health (ELV) United States $88.026B 11.36
CVS Health (CVS) United States $80.784B 10.04
Cencora (COR) United States $55.036B 19.15
DiDi Global (DIDIY) China $23.580B 35.79
Natera (NTRA) United States $22.420B 0.00
BioMerieux (BMXMF) France $16.097B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.007B 0.00
Solventum (SOLV) United States $12.962B 13.72
CochLear (CHEOY) Australia $11.342B 0.00
ICON (ICLR) Ireland $11.283B 10.49
Revvity (RVTY) United States $10.948B 18.84
Doximity (DOCS) United States $10.905B 50.49
Viatris (VTRS) United States $10.340B 3.55
HealthEquity (HQY) United States $9.613B 42.11
Avantor (AVTR) United States $9.165B 13.32
Medpace Holdings (MEDP) United States $8.574B 22.77
Sonic Healthcare (SKHHY) Australia $8.388B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.238B 24.96
BrightSpring Health Services (BTSG) United States $4.157B 38.48
Sotera Health (SHC) United States $3.508B 19.93
Surgery Partners (SGRY) United States $2.994B 38.93
Alignment Healthcare (ALHC) United States $2.924B 0.00
Concentras Parent (CON) United States $2.830B 16.36
Organon (OGN) United States $2.537B 2.70
GeneDx Holdings (WGS) United States $2.066B 79.58
Ardent Health Partners (ARDT) United States $1.957B 8.34
Premier (PINC) United States $1.900B 14.43
Progyny (PGNY) United States $1.883B 41.45
PACS (PACS) United States $1.586B 0.00
GoodRx Holdings (GDRX) United States $1.468B 29.36
Teladoc Health (TDOC) United States $1.298B 0.00
Pediatrix Medical (MD) United States $1.214B 9.24
Establishment Labs Holdings (ESTA) $1.113B 0.00
CareDx (CDNA) United States $1.098B 17.15
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.944B 0.00
AMN Healthcare Services Inc (AMN) United States $0.818B 7.66
QDM (QDMI) Hong Kong, SAR China $0.752B 0.00
Nutex Health (NUTX) United States $0.654B 9.90
Embecta (EMBC) United States $0.579B 3.90
LifeMD (LFMD) United States $0.566B 0.00
Enhabit (EHAB) United States $0.546B 44.92
InnovAge Holding (INNV) United States $0.520B 0.00
SBC Medicals (SBC) United States $0.507B 0.00
Sonida Senior Living (SNDA) United States $0.472B 0.00
Auna S.A (AUNA) Luxembourg $0.471B 10.60
COMPASS Pathways (CMPS) United Kingdom $0.437B 0.00
Performant Healthcare (PHLT) United States $0.244B 0.00
Oncology Institute (TOI) United States $0.232B 0.00
Beauty Health (SKIN) United States $0.202B 0.00
DocGo (DCGO) United States $0.163B 26.67
KindlyMD (KDLY) United States $0.150B 0.00
Pheton Holdings (PTHL) China $0.099B 0.00
So-Young (SY) China $0.091B 0.00
Basel Medical Group (BMGL) Singapore $0.081B 0.00
KindlyMD (NAKA) United States $0.081B 0.00
OncoCyte (OCX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.058B 0.00
Sera Prognostics (SERA) United States $0.057B 0.00
ModivCare (MODV) United States $0.050B 0.00
Biodesix (BDSX) United States $0.042B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00